A Successful Senior Quality Manager II at Bristol Myers Squibb, with over 20 years’ experience working in a regulated environment including: Cell Therapy, Pharmaceuticals, Molecular Diagnostics, Medical Device, Dietary Supplements, and Consumer Health industries, etc.
Overview
14
14
years of professional experience
Work History
Senior Quality Manager II
Celgene/ Bristol Myers Squibb
03.2021 - Current
Manages and oversees quality events emanating from BMS Summit 12’s Manufacturing Shared Services (MSS) Value Stream that comprise of S12 Supply chain, Manufacturing Shared Services Production Organization, Contract Manufacturing Organization (Markens and Cellex facilities.), QC Incoming, Facilities and Engineering dept, and Equipment, Calibration and Qualification (ECQ), departments
Ensure that quality events arising from these areas are effectively investigated and closed on time, with appropriate CAPA and Effectiveness checks identified and implemented
Manages and oversee QA staff that review and approve such quality events
Effectively oversee the training, growth, and development of my staff
Regularly provide guidance, coaching and training as needed to my direct reports that translates into increased team efficiency, output, continuous improvement, and growth
Contribute to the training and development of the entire QA Technical Operations deviation department staff through various technical presentations shared with the department staff
Successfully led internal and external cross-functional teams and resolved internal and external site conflicts
Recently, initiated and led a series of high-level meetings between QA Cell Therapy Manufacturing S12; QA External Manufacturing CTDO Patient Material; QA Global Apheresis Operations; and Global MSAT Cell Therapy Packaging Technology, that resolved multi-site disagreements emanating from handling of multi-site deviations due to Temperature Excursion quality events (with regulatory impacts) observed during Apheresis Transportation and receipt at S12
I spearheaded and defined an acceptable path forward to handling such deviations involving multiple BMS sites
Ensured that both global stakeholders and our MSS value stream customers and QA staff were trained on the solution articulated
Resolved multisite conflicts arising from ownership of Marken, and/or Cellex (CMO’s) related deviations
Successfully organized cross-functional meetings comprising of North American S12 Supply Chain Systems and Compliance
Strategy and Business Operations (warehouse); Europe’s Scheduling & Cell Logistics
CTDO Patient Operations Org; the Warehouse & Distribution Hub Cell Therapy Europe, and Cell Therapy Global External Manufacturing and Supply Chain Quality teams, that resulted in the following: Identification of appropriate site owners of finished Drug Product quality events observed at Marken
Identification of appropriate site owners of quality events originating from Cellex but observed at S12
Establishment of point contact between Europe’s Scheduling, Cell Therapy and Logistics Team (SCLT) and S12’s Warehouse/Supply Chain System and Compliance, to ensure effective transfer of information pertaining to quality events arising from BMS drug products distributed in Europe through Markens
Establishment of point contact between S12 and Cell Therapy Global External Manufacturing and Supply Chain Quality, to ensure effective transfer of information pertaining to quality events arising from Cellex during receipt of incoming Leukapheresis, CMAT, and PBMC at S12
Ensured that quality events arising from BMS Drug Products distributed in Europe (through Markens), and/or due to Receipt of Incoming Leukapheresis, CMAT, and PBMC from Cellex, are effectively processed following governing procedure, QMS SOP-13-2A
BMS Business Technical Approver (BTA) of critical, major, and minor deviations that make it to the Investigation Review Board (IRB) and CAPA Review Board (CRB)
Also, an active member of BMS IRB/CRB
Aging Deviation Clinic: Ran the aging deviations clinic at BMS Summit site that significantly drove down the number of deviation records that have exceeded their due dates, through providing guidance and assistance to Lead Investigators, which enabled them overcome various roadblocks that originally hindered their deviation closure on-time
QA Deviation Clinic: Actively coordinated and assisted Manufacturig Science and Technology (MSAT) deviation Investigators that walked-in to this clinic with answers that helped remove roadblocks they encountered during investigations
Was the sitewide Owner of BMS Summit 12 Monthly trending of deviations for potential trends (Jan2023 – Apr2023) that resulted in efficient closing of deviations, identification of potential trends, opening of trend investigations that addressed potential trends, and ensured that RCA resulted in appropriate CAPA’s for them
Prepared, coordinated, and ran cross-functional daily Breyanzi and Abecma Products Huddle meetings in 2022
Conducted gap analysis of newly generated quality events and assigned action item owners to close identified gaps, thereby facilitating on time generation and completion of newly generated deviation records within its given lifecycle
Ensured timely review of manufacturing and laboratory investigations of over 30 lead investigators
Have passionately driven efficiency at BMS with bold solutions and recommendations that has ensured continuous improvement in the site’s handling of deviations
An insightful recommendation to BMS S12’s Site Leadership Team, was implemented and it contributed to the discontinuation of a Non GMP eTriage system of deviation management, and the use of a “Deviation Sweeper” to drive efficiency
Have successfully worked with various cross-functional teams at BMS to drive solutions that included on-time shipping of patient lots, on-time closure of deviation records, on-time mitigation plans, and on-time CAPA's
Work with manufacturing and laboratory management to ensure investigations comply with global regulatory requirements
Provide quality oversight to Interim Disposition Assessments and Initial Impact Assessments by Subject Matter Experts pertinent to the disposition of deviation impacted patient lots
Participate in Material Review Board (MRB) meetings for the disposition of patient lots impacted by a deviating quality event
Ensure that MRB decisions are effectively captured in the quality system’s electronic database prior to the disposition of a nonconforming patient lot
Very good with the Infinity database for quality event
Six Sigma White belt certified.
Senior Quality Investigator
Auro Packaging LLC – A Subsidiary of Aurobindo Pharma USA Inc.
07.2020 - 03.2021
Led, conducted, wrote, reviewed, and approved quality investigations that pertained to over the counter and prescription drugs manufactured by Aurobindo Pharma USA and packaged at Auro packaging LLC
Was in-charge of market complaint investigations, root cause analysis, correction, corrective actions, and preventive actions (CAPA)
Responsible for maintenance of quality assurance investigation database and market complaint trend analysis, etc
Ensured that quality investigations were completed, written, and approved in a timely manner
Provided awareness training to Quality assurance and Packaging staff as needed.
Senior Quality Investigator
PharMeDium Health Corporation – A Subsidiary of AmerisourceBergen Corp
05.2019 - 07.2020
Provided quality oversight to quality control laboratory and manufacturing processes
Carried out root cause analysis investigation of laboratory and manufacturing nonconformances and/or deviations
Identified root cause, correction, corrective actions, and preventive actions
Oversaw their implementations
Wrote, reviewed, and approved investigation reports
Ensure that quality investigations are completed, written, and approved in a timely manner
Collaborated with cross functional teams and provided guidance and resolutions to manufacturing and/ or quality control issues
Recommended quality process improvements to increase efficiency and performance of systems, operations, and personnel and prevent recurrence of incidents or events
Trained junior quality control and quality assurance investigators to conduct manufacturing and quality control deviation investigations
Ensured that manufacturing instructions, standard operating procedures and pertinent quality documents identified for updates and revisions, are completed in a timely manner and implemented
Assisted with regulatory/compliance/customer audits
Utilized the MasterControl quality systems electronic database.
Performed laboratory and manufacturing investigations: Out of specifications (OOS), out of trends (OOT), deviations etc
Wrote investigation reports, generated CAPA and/or SCAR
Reviewed investigation reports
Coordinated, and ensured that non-conformances were adequately investigated for determination of root cause and product impact per FDA regulations
Ensured that root causes, corrections, corrective actions, and preventive actions were effectively identified and implemented to ensure conformance, avoid recurrence and prevent occurrence
Performed trend analysis
Assisted with regulatory/compliance/customer audits
Interfaced in a collaborative team environment with Manufacturing, Quality Control, Quality Assurance, Operations, Maintenance, Technical Support, and other departments to resolve quality problems
Utilized TrackWise quality systems electronic database.
Senior Quality Engineer (Contract Position)
Zimmer Biomet (Compression Therapy Concepts)
06.2016 - 03.2017
Remediation and integration of Compression Therapy Concept’s (CTC) Quality Management System into Zimmer-Biomet’s
Ensured that CTC processes and procedures were in compliance with ISO13485 and 21 CFR Part 820
Authored and executed Operation Project Plans for complaint remediation and integration
Remediated CTC’s Complaint and Repair Processes to conform with ISO13485
Revised/authored various Quality Standard Operating Procedures and Work Instructions, including: Good Manufacturing Practice, Complaint Handling Procedure, Return Goods Authorization (RGA) procedure and others for the company
Trained CTC employees on the remediated procedures
Performed quality engineering reviews of device history records to ensure compliance with stated requirements.
Quality Manager (Contract Position)
Tekni-Plex
10.2015 - 03.2016
Oversaw the Quality Assurance/Quality Control department
Managed QA/QC staff comprising of 3 shifts and over 15 employees
Ensured that test procedures and product specifications were properly written, reviewed, approved, documented, and carried out in accordance with GMP
Oversaw the review and disposition of nonconforming materials and products
Effectively interacted with Production and Development teams to maintain product supply and launch new products
Oversaw customer complaints, root cause analysis, corrective and preventive actions, and supplier corrective actions
Ensured that product specifications met customer requirements
Authored Quality Plans for customers
Worked with purchasing staff to establish quality requirements from external suppliers
Oversaw customer audits and responses
Prepared Quality KPI’s for company’s management review meetings
Worked to remediate and address various FDA 483 observations within Zimmer corporation
Wrote, reviewed, and approved Validation Protocols and Reports (IQ, OQ, PQ), Deviations, Investigation Reports, etc
Led TSV TM Dental shells process improvement team and provided technical expertise as needed
Worked with manufacturing and Quality Control to established in-process monitoring specifications for the TSV TM Dental shells line of products
Gathered relevant information and data needed to solve quality related problems that pertained to the TSV TM Dental Shells manufacturing process.
Quality Manager
NutraBio Inc
11.2010 - 09.2014
Oversaw the setup of an entire quality control laboratory for this company
Hired and trained Quality Control dept
Staff
Wrote most of the standard operating procedures for this company and ensured that they conformed to the 21CFR Part 111 that guided the dietary supplement industry
Scheduled and oversaw all laboratory operations for testing, review and release of raw materials, intermediates and finished products to ensure compliance with company and FDA guidelines
Ensured that appropriate analytical methods were developed and validated for raw materials, intermediates and finished products
Managed and oversaw the company’s approval process for suppliers and/or manufacturers of raw ingredients
Managed, approved and oversaw external laboratories utilized by Nutrabio Inc
As needed, for raw materials and finished products analysis
Oversaw the review and disposition of nonconforming products
Oversaw corrective actions and preventive actions (CAPA)
Oversaw company’s Consumer Complaints and their documentation
Very experienced with FDA Surveillance Audits, 483 Observations/Responses and 21 CFR Part 111.
Education
PhD Chemistry -
University of Connecticut
Skills
Quality Assurance
Excellent Communication & interpersonal skills
Teamwork and Collaboration
Quality Management
Leadership and team management
Strong Organizational Skills
Employee training & Supervision
Time management
Problem Solving & Critical thinking
CAPA
Continuous Improvement
Regulatory Compliance
Product quality
Attention to details
Customer service
Documentation
Strong Work Ethic
Multitasking
Decision-Making
Relationship Building
Team building
Task Prioritization
Patents & Publications
Available on Request
References
Available on Request
Timeline
Senior Quality Manager II
Celgene/ Bristol Myers Squibb
03.2021 - Current
Senior Quality Investigator
Auro Packaging LLC – A Subsidiary of Aurobindo Pharma USA Inc.
07.2020 - 03.2021
Senior Quality Investigator
PharMeDium Health Corporation – A Subsidiary of AmerisourceBergen Corp